# Trans-septal delivery of hydrogel-encapsulated human umbilical cord MSC-derived neurospheres for acute neuroprotection in traumatic brain injury

**Authors:** Dong Wook Kim, Ok Joo Lee, Bo Young Choi, Md. Tipu Sultan, Olatunji Ajiteru, Min Kyu Park, Ji Seung Lee, Soon Hee Kim, Kyu Young Choi, Sang Won Suh, Chan Hum Park

PMC · DOI: 10.1063/5.0288289 · 2026-01-06

## TL;DR

This study shows that hydrogel-encapsulated human umbilical cord stem cell-derived neurospheres can protect the brain and improve recovery after traumatic brain injury in rodents.

## Contribution

The novel approach of using hydrogel-encapsulated hUC-MSC-derived neurospheres for acute neuroprotection in TBI is demonstrated for the first time.

## Key findings

- Trans-septal delivery of hydrogel-encapsulated neurospheres reduced neuronal damage and improved neurological outcomes in a TBI model.
- Encapsulation in hydrogel enhanced cell survival and neuroprotective effects in co-cultured HT22 cells and in vivo.
- Neurospheres preserved dendritic integrity and reduced neurodegenerative markers in hippocampal regions after TBI.

## Abstract

This study explores the therapeutic potential of hydrogel-encapsulated neurospheres derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) in mitigating traumatic brain injury (TBI) and enhancing functional recovery in a rodent model. Trans-septal (intranasal) transplantation of these neurospheres demonstrated significant neurological improvement, reduced neuronal damage, and preserved neuronal structures and functions. The hUC-MSCs cultured in a customized bioreactor retained essential MSC characteristics, including marker expression and multi-lineage differentiation potential, ensuring their therapeutic efficacy. Following neural induction, hUC-MSCs formed neurospheres that promoted cell aggregation, differentiation, and neuroprotective effects. Encapsulation within a hydrogel provided a stable environment, significantly reducing TBI-induced cell death in co-cultured HT22 cells and improving in vivo outcomes. Therapeutic benefits were evidenced by decreased modified neurological severity scores (mNSS), improved ΔmNSS, and restoration of neurotrophic factors, such as brain-derived neurotrophic factor in the hippocampal CA1 region, which supports cognitive and memory functions. Immunohistochemical and immunofluorescence analyses confirmed the neurospheres' ability to mitigate TBI-induced neurodegeneration, oxidative stress, and dendritic damage. Reduced neurodegenerative markers and preserved dendritic integrity, particularly microtubule-associated protein 2 expression in the CA1 and dentate gyrus (DG) regions, underscore the potential of hUC-MSC–derived neurospheres in maintaining neural connectivity and function after TBI.

## Linked entities

- **Diseases:** traumatic brain injury (MONDO:0858950)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}
- **Diseases:** TBI (MESH:D000070642), neurodegeneration (MESH:D019636), dendritic damage (MESH:D007635), neuronal damage (MESH:D009410)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12779357/full.md

---
Source: https://tomesphere.com/paper/PMC12779357